by Jessica Etheridge | Jul 20, 2023 | Articles, Colorectal Cancer
Introduction The gastrointestinal (GI) tract plays a vital role in the ability to digest and absorb nutrients from food. The GI tract is inhabited by a diverse community of microorganisms that provide nutrients and protection while breaking down hard to digest foods....
by Jessica Etheridge | Nov 1, 2021 | ColoPlex, Colorectal Cancer, Product Pipeline
Luminex Licensed Technologies Partner Spotlight: EDP Biotech Early detection makes a real difference in outcomes for cancer patients. But for cases of colorectal cancer, detecting tumors in the earliest stages has been virtually impossible. The team at EDP Biotech is...
by Jessica Etheridge | Dec 14, 2020 | ColoPlex, Colorectal Cancer
EDP Biotech Poster Presentation at AACC This week the newest data results from EDP Biotech’s multiplex study involving nearly 2,000 individuals from colorectal cancer organized screening are being presented virtually this week at the 2020 American Association...
by Jessica Etheridge | Oct 2, 2020 | ColoPlex, Colorectal Cancer, Featured, News and Events
ACS Cancer Action Network Tennessee Policy Forum: Precision Medicine and Biomarkers EDP Biotech participated in the September 23rd American Cancer Society – Cancer Action Network Tennessee Policy Forum focused on work being done in the field of Precision...
by Jessica Etheridge | Dec 3, 2019 | Articles, Colorectal Cancer, News and Events
Doctor Anna talks colorectal cancer with Eric Mayer and Jason Liggett, Ph.D from EDP biotech, a company that is focused on early detection methods for this devastating disease. Listen on YouTube!
by Jessica Etheridge | Jun 3, 2019 | Articles, ColoPlex, Colorectal Cancer, Featured, News and Events
NEW YORK (GenomeWeb) – In vitro diagnostics developer EDP Biotech said today it has signed a deal with Luminex to develop, market, and sell a blood-based colorectal test using the xMAP technology. Terms of the deal were not disclosed. Called ColoPlex, the inexpensive...
